|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| C07D 209/52 | (2006.01) |
| (11) | Number of the document | 2719384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13189441.2 |
| Date of filing the European patent application | 2006-07-25 | |
| (97) | Date of publication of the European application | 2014-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (30) | Number | Date | Country code |
| 703364 P | 2005-07-27 | US |
| (72) |
Skolnick, Phil, US
Basile, Anthony, US
Chen, Zhengming, US
Epstein, Joseph W., US
|
| (73) |
Otsuka America Pharmaceutical, Inc.,
2440 Research Boulevard, Rockville, MD 20850,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Nauji 1-naftil-3-azabiciklo[3.1.0]heksanai: gamyba ir panaudojimas neuropsichiatrinių sutrikimų gydymui |
| NOVEL1-NAPHTHYL-3-AZABICYCLO[3.1.0]HEXANES:PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 20 | 347.00 EUR |